Compounds > indirubin-3'-monoxime
Page last updated: 2024-10-29

indirubin-3'-monoxime and Acute Lymphoid Leukemia

indirubin-3'-monoxime has been researched along with Acute Lymphoid Leukemia in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, MY1
Liu, YW1
Chen, MH1
Wu, JY1
Ho, HY1
Wang, QF1
Chuang, JJ1

Other Studies

1 other study available for indirubin-3'-monoxime and Acute Lymphoid Leukemia

ArticleYear
Indirubin-3'-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells.
    Oncology reports, 2013, Volume: 29, Issue:5

    Topics: Apoptosis; Autophagy; Caspase 3; Cell Death; Cell Division; Cell Line, Tumor; Cell Survival; G2 Phas

2013